MannKind | MNKD - Interest Income


MannKind reported $1.83M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
Dynavax Technologies USD 6.8M 941K Jun/2025
Eli Lilly USD 65M 25M Sep/2025
Insmed USD 765K 55K Sep/2024
MacroGenics USD 1.53M 114K Sep/2025
MannKind USD 1.83M 124K Jun/2025
Merck USD 96M 27M Sep/2025
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Xencor USD 7.25M 290K Jun/2025